Hyperlysinemia, Type I (HYPLYS1)

Alias:
Hyperlysinemia
Lysine Alpha-Ketoglutarate Reductase Deficiency
Hyperlysinemia Type I
Lysine Intolerance
Lysine Alpha-Ketoglutarate Reductase Deficiency Disease
Alpha-Aminoadipic Semialdehyde Synthase Deficiency
Alpha-Aminoadipic Semialdehyde Deficiency Disease
Lysine:alpha-Ketoglutarate Reductase Deficiency
L-Lysine:nad-Oxido-Reductase Deficiency
Saccharopinuria
Hyperlysinemias
Saccharopine Dehydrogenase Deficiency Disease
Saccharopine Dehydrogenase Deficiency
Familial Hyperlysinemia
Hyperlysinemia, 1
Hyplys1
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Hyperlysinemia, Type I, also known as hyperlysinemia, is related to 2,4-dienoyl-coa reductase deficiency and argininemia, and has symptoms including seizures An important gene associated with Hyperlysinemia, Type I is AASS (Aminoadipate-Semialdehyde Synthase), and among its related pathways/superpathways are Metabolism and Regulation of expression of SLITs and ROBOs. Affiliated tissues include cortex and kidney, and related phenotypes are intellectual disability and seizure
Related ID:

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
AR
All ages
--
14
81
17

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top